Lanreotide in metastatic enteropancreatic neuroendocrine tumors

N Engl J Med. 2014 Oct 16;371(16):1556-7. doi: 10.1056/NEJMc1409757.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Male
  • Neuroendocrine Tumors / drug therapy*
  • Pancreatic Neoplasms / drug therapy*
  • Peptides, Cyclic / therapeutic use*
  • Somatostatin / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Peptides, Cyclic
  • Somatostatin